DatasetName,CSTF3_S(691),CSTF3_S(2) CSTF3_S(65) CSTF3_S(723) CSTF3_T(266) CSTF3_T(273) CSTF3_T(334)
RM2024_Intensity D4-1___3,,
RB2022_4_PostEndurance,,
FSO2013_Ratio M/L normalized Rep3,0.4831312169466896,
SR2019_MCF7_Biol_repl_3,0.5616927606734479,
RKK2015_IKKb(K44M)+TNF-α/IKKb(K44M),,
SR2019_LM2_Biol_repl_1,,
RCJD2014_15min_1,,
AS2011_Ratio H/L Normalized by Proteins Inhi_1,,
CK2022_7 16-1,0.7298828875258033,
NJH2025_Sub12_HIIT_Mid,,
AH2018_LFQ_IT_1_C,,
RKK2015_TNF-α/basal,,
JJ2018_Ratio H/M normalized pP2,,
NJH2025_Sub12_MICT_Pre,,
NJH2025_Sub7_MICT_Post,,
DL2023_control-3,,
ZX2022_Control Replicate 2,0.6865506336657112,
HS2024_6_B_T3,0.6082973536711809,
JW2015_Intensity pre1,,
IMM2018_normalised rep. int. Empty-3,0.5627279189759586,
AMK2021_30R_p5,,
FSO2013_Ratio M/L normalized Rep1,0.5639245428600564,
SR2019_MDAMB231_Biol_repl_4,,
GF2025_P2_Sph,0.5356344093721418,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt2b,,
NJH2025_Sub13_HIIT_Mid,,
CP2009_Ratio M/L,,
NJH2025_Sub7_HIIT_Post,,
KBE2022_Log2_Ex_44_T,0.7799020359320945,0.5321725537288432
DB2022_Intensity L2,,
TM2022_mock.4h.C,,
AST2020_anti-CD3.2,,0.5416299984000918
CW2012_10 µM Erl/control Experiment 1 Replicate B,,
HS2024_7_B_N1,0.5631882439635933,
FSO2013_Ratio M/L normalized Rep1___1,0.5638215146198956,
SAS2015_AZD/DMSO_Exp3,,
RM2024_Intensity D0-2___3,,
RM2024_Intensity D6-1,,
RB2022_8_RecoverySprint,,
RB2022_5_PreEndurance,,
CKC2017_log2 normalized phosphoproteomics_30min_rep#2,,
EP2017_Untreated R#4 normalized log2 ratio,,
WZ2023_Pu_010_30min,0.6066180658313926,0.5335305624217822
AS2011_Ratio H/L Proteins RNAi_2,,
RB2022_4_PreStrength,,
NJH2024_Sub4_MICT_Post,,
AH2018_LFQ_M_1_X,,0.5179844254637467
RB2022_8_RecoveryEndurance,,
KBE2022_Log2_Ex_14_U,0.794781377607149,0.5331287248328979
FSO2013_Ratio M/L normalized Rep3___3,,
AH2018_TMTMS3_1_C,,
JJ2018_Ratio H/L normalized___1,,
ZQ2022_C2,0.609892078612275,
RB2022_5_PreSprint,,
PG2020_Intensity 8h_C,0.525384627100173,
AH2018_SILAC_MR_2_N,,0.511412908971778
MV2014_Ratio M/L normalized A1___2 (2 min),,
TM2022_S2.8h.B,,
MV2014_Ratio M/H normalized B3___1 (30 min),,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as4a,,
RNJ2017_Log2_ratio_Tsup:Tstim_D2,,
RM2024_Intensity D6-1___2,,
NJH2025_Sub7_MICT_Mid,,
LY2019_P1+,0.4938114688767803,0.5279578580262211
AS2011_Ratio H/L Proteins Inhi_2,,
BS2014_Log2(Ratio H/L normalized),,
UK2020_HCM_2,0.5545035719612825,0.5283434849167733
FSO2013_Ratio H/L normalized Rep2___2,,
EP2017_Pervanadate R#3 normalized log2 ratio,,
RM2024_Intensity D4-3___3,,
RB2022_5_PreStrength,,
NJH2024_Sub4_MICT_Mid,,
TM2022_S2.4h.A,,
RB2022_5_PostStrength,,
GF2025_P6_Sph,0.5074772436292436,
RB2022_2_PreSprint,,
ZX2022_CB treated Replicate 3,0.687596302964259,
RM2024_Intensity D6-2___3,,
WZ2023_Pe_025_10min,0.7125691467974876,0.5321171899966178
AS2011_Ratio H/L Normalized by Proteins RNAi_1,,
AST2020_anti-CD3+PDL2.1,,0.5420568042181475
KBE2022_Log2_Ex_34_U,0.81301857405097,0.5300380270764632
WZ2023_Pu_005_10min,0.7181906023794642,0.5309941051564184
AS2011_Ratio H/L RNAi_2_1,,
NJH2024_Sub9_HIIT_Mid,,
CK2022_9 40-1,0.7988481112446486,
KTGR2014_Ratio H L Normalized Rep1_Rapamycin_0_15,0.3669064656286934,
LG2023_GSK3α-1_intensity,,
WZ2023_Pu_025_30min,0.6791589118508062,0.5318908836678616
AH2018_SILAC_MR_2_X,,0.5087931155701242
HS2024_4_PD_T2,0.6011875387889846,
NJH2024_Sub4_HIIT_Pre,,
RB2022_2_RecoverySprint,,
AS2011_Ratio H/L Protein RNAi_1,,
RM2024_Intensity D2-1___2,,
CR2017_Ratio Replicate 1.4,0.5709931446710911,
FR2021_Norm.Intensity.B,0.8303381844939246,
RM2024_Intensity D6-2___1,,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.2-1,,
RB2022_5_PostSprint,,
EJN2021_3_Rest_Basal,,0.5259068311290296
CR2017_Ratio Replicate 1.3,,
AS2011_Ratio H/L Normalized by Protein RNAi_2,,
KTGR2014_Ratio-Rapa 7 mins,0.5007722453210102,
AMK2021_120R_p1,,
AH2018_SILAC_3_X,,
JJ2018_Ratio M/L normalized pP3,,
AH2018_SILAC_M_2_N,,
HS2024_7_PD_T2,0.4266509019689399,
FSO2013_Ratio H/L normalized Rep1___1,0.53632884962182,
AH2018_LFQ_1_C,,0.5063217617492443
AS2011_Ratio H/L Normalized Inhi_1_3,,
KBE2022_Log2_Ex_28_T,0.7220379646216689,0.5386736376309517
HS2024_3_B_N1,0.5162663677933977,
RM2024_Intensity D4-2___3,,
WZ2023_Pe_025_30min,0.6746045204693357,0.5310995073281479
CK2022_11 40-1,0.806814275353166,
CW2012_10 µM Erl/control Experiment 3 Replicate B,,
AH2018_SILAC_2_X,,
MV2014_Ratio H/M normalized A2___2 (2 min),,
AS2011_Ratio H/L RNAi_1_2,,
KS2014_Intensity E15_1,,
FSO2013_Ratio H/L normalized Rep2,0.5674257067658363,
WZ2023_Pu_005_20min,0.5732962059963849,0.5321303476264342
NJH2024_Sub10_MICT_Post,,
RM2024_Intensity D2-3___1,,
CR2017_Ratio Replicate 1.5,0.5618321640067043,
CW2012_10 µM Gef/control Experiment 2 Replicate B,,
HS2024_7_B_T3,0.5623664869603843,
CKC2017_log2 normalized phosphoproteomics_60min_rep#1,,
AS2011_Ratio H/L RNAi_1,,
JC2019_Normalised_intensity_A_TiOx_Testis_sample_URO0059,,
AH2018_LFQ_M_1_C,,0.5158766538454848
NJH2025_Sub7_MICT_Pre,,
SR2019_SKBR3_Biol_repl_2,,
HS2024_9_B_T2,0.5025589695144531,
KTGR2014_Ratio-AA 7 mins,0.4946583367328813,
MV2014_Ratio L/H normalized B3___3 (5 min),,
HS2024_3_PD_T1,0.5332516957722723,
FSO2013_Ratio M/L normalized Rep3___2,,
SR2019_BT549_Biol_repl_3,,
RCJD2014_20min_mean,,
FR2021_Norm.Intensity.H,0.8129481987926824,
RB2022_2_PreStrength,,
DB2022_LFQ intensity L1.2,,
HS2024_4_B_N1,0.5296725900744106,
KTGR2014_Ratio H M Normalized Rep2_Rapamycin_0_15,0.3942815056306608,
CK2022_1 16-1,0.7598892471993165,
CK2022_1 200-1,0.8006517340454561,
PG2020_Intensity Mock_10h_D,0.5447567625861693,
SR2019_MCF10A_Biol_repl_2,0.6041985849326702,
JJ2018_Ratio M/L normalized pP2___2,,
HS2024_6_PD_T1,0.5223322436341261,
JVO2010_Ratio M/L Normalized by Protein ThymON - Log2 G1/S,0.52633217855014,0.5275881444930649
RB2022_6_RecoveryEndurance,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt3b,,
EP2017_Mitotic R#2 normalized log2 ratio,,
RCJD2014_5min_1,,
RM2024_Intensity D4-1___1,,
DL2023_24h-1,,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.1-1,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as2b,,
TM2022_S2.4h.C,,
SAS2015_PLX/AZD_Exp2,,
CR2017_Ratio Replicate 3.3,0.6302570259796815,
PG2020_Intensity 2h_C,,
VOI2024_Veh2 di,,
ZX2022_CB treated Replicate 2,0.6840818389749427,
KBE2022_Log2_Ex_8_T,0.7455351886913778,0.5384689953338672
NJH2025_Sub10_MICT_Post,,
HS2024_6_I_T3,0.4164169337660887,
RN2012_L11,,
AS2011_Ratio H/L Normalized Inhi_2_2,,
IMM2018_normalised rep. int. Empty-1,0.5707635748425165,
HS2024_5_PD_T1,0.548369176114286,
AH2018_LFQ_M_2_C,,0.5232633299221018
CK2022_3 40-1,0.7998862238546579,
RBK2021_1260T Early,,
NJH2024_Sub4_HIIT_Post,,
HS2024_4_I_T1,0.5933701674228581,
YA2020_Reporter_intensity_Cancer_No.5,,
HH2022_Reporter intensity 8,,
ZQ2022_N2,0.4633934986606531,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt1b,,
FSO2013_Ratio H/L normalized Rep3___3,,
AH2018_TMTMS3_2_N,,
EJN2021_5_Rest_Basal,,0.5284583123704911
NJH2025_Sub2_HIIT_Post,,
NJH2025_Sub1_MICT_Post,,
HS2024_9_B_T1,0.4525407839436348,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt1a,,
JAW2011_Ratio H/L LS2_1,0.5373225034398746,
JVO2010_Log2 Ratio H/M Normalized aphidicolin,0.4253828929186038,0.5263087453365173
NJH2024_Sub6_HIIT_Pre,,
AH2018_SILAC_3_N,,
YA2020_Reporter_intensity_Normal_No.1,,
HS2024_3_B_T1,0.5339481857115606,
JJ2018_Ratio H/L normalized___2,,
RM2024_Intensity D0-2,,
MV2014_Ratio M/L normalized B1___2 (5 min),,
RB2022_7_PostStrength,,
RB2022_1_PostEndurance,,
CR2017_Ratio Replicate 3,0.6164958678996494,
SR2019_Hs578T_Biol_repl_3,0.3405899960936101,
MV2014_Ratio L/H normalized B3___1 (5 min),,
RBK2021_1244T Early,,
RB2022_3_PostSprint,,
NJH2024_Sub13_MICT_Mid,,
KTGR2014_Ratio-AA 2 mins,0.4600709035204026,
GF2025_P7_Sph,0.5356102204148593,
HS2024_8_I_T3,0.5567993312688594,
CF2017_EOC 3,0.6187449093479419,
LATM2013_Normalized Log2 Ratio (Medium/Light) Forward,0.3726687257754903,
HS2024_6_PD_T3,0.4073555932671533,
DL2023_12h-2,,
RM2024_Intensity D6-3___1,,
FS2019_Ctr1,,
WZ2023_Pu_010_20min,0.683628315711239,0.5323194235468798
AS2011_Ratio H/L_3,,
CK2022_1 40-1,0.810520362499861,
RNJ2017_Log2_ratio_Tsup:Trest_D1,,
CK2022_8 16-1,0.7294702294127751,
KS2014_Intensity N3,,0.527969525897611
RB2022_4_RecoveryEndurance,,
RB2022_5_RecoveryEndurance,,
JAW2011_Ratio H/L LS1a_2,,
NJH2024_Sub12_HIIT_Mid,,
AH2018_LFQ_IT_1_N,,
FSO2013_Ratio H/M normalized Rep2,0.477632626824216,
RAM2015_Log2 A,0.5265937963780435,
HS2024_8_PD_T1,0.4866206415336006,
JJ2018_Ratio H/L normalized pP2,,
CF2017_OSE 27,0.322366760134648,
KS2014_Intensity E15_2,,
BS2014_Log2(Ratio H/L protein),,
PG2020_Intensity 8h_A,0.4415077646400456,
HS2024_7_I_T1,0.6413500749245947,
VOI2024_Veh3 di,,
RKK2015_TNF-α+SC-514/basal,,
SR2019_JIMT1_Biol_repl_1,0.5027170004341619,
HW2015_Ratio H/L normalized Exp2,,
HS2024_3_I_N1,0.6032821299162667,
AH2018_SILAC_M_3_X,,
NJH2024_Sub9_HIIT_Post,,
AS2011_Ratio H/L RNAi_1_3,,
GRW2016_Ratio H/L normalized SILAC 1___2,,
NJH2025_Sub1_HIIT_Pre,,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.1-2,,
NJH2024_Sub4_HIIT_Mid,,
VOI2024_0.1uM 2 h_1 di,,
KBE2022_Log2_Ex_6_T,0.7826900041314122,0.5328880305986615
RM2024_Intensity D4-3___1,,
AH2018_LFQ_4_X,,
AS2011_Inhi 2_Ratio H/L normalized by corresponding protein level (H:TAL treatment; L: MA treatment),,
RB2022_8_PostEndurance,,
NJH2025_Sub4_MICT_Mid,,
YP2020_Intensity C30_R1_mult_log2,0.7676063139979091,
AST2020_anti-CD3.1,,0.5428264027553936
NJH2025_Sub4_HIIT_Post,,
EP2017_Untreated R#4 log2 ratio,,
HS2024_6_B_N1,0.4929809256363789,
KBE2022_Log2_Ex_27_T,0.8146607603934414,
CW2012_10 µM Gef/control Experiment 1 Replicate A,,
VOI2024_0.1uM 24 h_1 mono,,
AMK2021_120R_p5,,
AS2011_Ratio H/L Proteins,,
NJH2024_Sub7_HIIT_Post,,
NJH2015_TMT Subject 1 127_N/126 (Exercise/Basal) (normalized),,
AS2011_Ratio H/L RNAi_2_2,,
RB2022_7_RecoveryStrength,,
AH2018_SILAC_IT_3_X,,
JAW2011_Ratio H/L,0.5195613634416597,
PG2020_Intensity 10h_C,0.4719000138061682,
FSO2013_Ratio M/L normalized Rep2,0.5300944670161186,
CP2009_Ratio H/M Normalized (50 nM dasatinib vs 5 nM dasatinib),,
HH2022_Reporter intensity 5,,
SR2019_HCC1954_Biol_repl_2,0.4597499741960369,
CK2022_14 40-1,0.7107401670658114,
RB2022_6_PreSprint,,
NJH2025_Sub12_MICT_Mid,,
PG2020_Intensity 4h_D,0.6647549273345167,
NJH2025_Sub2_MICT_Post,,
AH2018_LFQ_4_C,,
DL2023_control-1,,
AR2021_ALG 10 μM,,0.5376353599019372
JAW2011_Ratio H/L LS2_2,,
AH2018_SILAC_IT_3_N,,
EJN2021_4_Rest_Ins,,0.5272282890027572
RN2012_H05,0.5682850013979751,
NJH2024_Sub7_HIIT_Mid,,
GF2025_P2_Adh,0.581157178974327,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as4b,,
RB2022_8_PostSprint,,
EJN2021_1_Rest_Ins,,0.5287175010846744
HH2022_Reporter intensity 3,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt4b,,
AH2018_SILAC_IT_1_C,,
JW2021_After_3,,
GF2025_P8_Sph,0.5704838089313794,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt4,,
JJ2018_Ratio M/L normalized pP2___1,,
AH2018_SILAC_2_N,,
CK2022_11 200-1,0.7943744256721632,
CK2022_12 200-1,0.7614924112405416,
AS2011_Ratio H/L Normalized by Protein RNAi_1,,
RM2024_Intensity D2-1___3,,
NJH2024_Sub1_MICT_Pre,,
HH2022_Reporter intensity 9,,
WZ2023_Su_010_20min,0.5841167358310767,0.5318763317865117
AH2018_TMTMS2_2_N,,
NJH2024_Sub13_MICT_Pre,,
KBE2022_Log2_Ex_41_U,0.7695044863968691,0.5358921344652883
NJH2015_TMT Subject 3 129_N/128_C (Exercise/Basal) (normalized),,
AH2018_TMTMS3_Pool,,
KS2014_Intensity N4,,0.5318195001209567
NJH2024_Sub1_HIIT_Post,,
MM2018_Ratio H/L replicate2,0.4121646117137109,
RM2024_Intensity D4-2___2,,
NJH2024_Sub13_HIIT_Pre,,
CF2017_OSE 26,0.2776674171881439,
CK2022_14 200-1,0.7542481050069287,
SR2019_Hs578T_Biol_repl_1,0.5161976995418264,
RB2022_7_PostSprint,,
TM2022_mock.4h.A,,
NJH2025_Sub12_HIIT_Pre,,
AH2018_TMTMS3_1_N,,
AST2020_anti-CD3+PDL2.2,,0.5420236257612806
PG2020_Intensity Mock_10h_A,0.4450103381653534,
JW2021_After_2,,
NJH2024_Sub2_MICT_Post,,
EJN2021_2_Rest_Ins,,0.5276894712021591
SR2019_LM2_Biol_repl_4,0.4929356278351818,
CP2009_Ratio H/M,,
JAW2011_Ratio H/L HS,0.5501226348488667,
CK2022_13 16-1,0.6713741432482114,
GF2025_P1_Adh,0.549310268773832,
GF2025_P1_Sph,0.5582969372563411,
EJN2021_5_Ex_Basal,,0.5201836666645222
HS2024_7_I_T3,0.5015598949187238,
JJ2018_Ratio H/L normalized pP2___2,,
WZ2023_Pe_010_10min,0.7061435795315842,0.5295930889466917
CF2017_EOC 1,0.4756455713793305,
CK2022_3 200-1,0.7997935029723452,
AH2018_LFQ_IT_3_C,,
SR2019_Hs578T_Biol_repl_2,0.4990954427053211,
NJH2024_Sub12_HIIT_Post,,
JJ2018_Ratio H/L normalized pP1___2,,
MV2014_Ratio H/L normalized A1___2 (10 min),,
NJH2024_Sub10_MICT_Mid,,
NJH2024_Sub13_MICT_Post,,
BS2014_Log2(Ratio H/L normalized Rep_1),,
RB2022_3_RecoverySprint,,
NJH2025_Sub1_HIIT_Mid,,
RCJD2014_20min_2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt2,,
HS2024_6_PD_T2,0.5290360284165692,
HS2024_5_B_T1,0.6145015321016789,
CW2012_10 µM Gef/control Experiment 2 Replicate A,,
DL2023_12h-3,,
SR2019_MDAMB231_Biol_repl_2,0.471816295845412,
HS2024_3_B_T2,0.5817538828517114,
RB2022_6_PreStrength,,
CK2022_2 40-1,0.8196797562008473,
RB2022_1_PostSprint,,
CK2022_4 200-1,0.7940979976546675,
JW2021_Before_2,,
TM2022_S2.12h.A,,
MV2014_Ratio L/M normalized B2___2 (30 min),,
CK2022_5 16-1,0.7251735823988688,
AR2021_ALG 1 μM,,0.49643532585777345
HS2024_4_B_T1,0.6033449656338524,
MV2014_Ratio M/H normalized A3___1 (10 min),,
SR2019_BT549_Biol_repl_4,0.4701968108337265,
EJN2021_1_Rest_Basal,,0.5203181273291478
NJH2025_Sub8_MICT_Post,,
RCJD2014_5min_3,,
CR2017_Ratio Replicate 3.2,0.5978621887294354,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as3a,,
GF2025_P7_Adh,0.5664153022968308,
CK2022_9 16-1,0.7470093307733163,
NJH2024_Sub6_HIIT_Post,,
AMK2021_30R_p3,,
AS2011_Ratio H/L Normalized RNAi_2,,
RM2024_Intensity D0-2___2,,
KS2014_Intensity pY_N4,,
CK2022_13 200-1,0.7488739950225644,
AS2011_Ratio H/L Normalized_2,,
PG2020_Intensity 6h_D,0.5283746506171753,
CK2022_16 16-1,0.6424410155102068,
FS2019_db/db3,,
CK2022_15 40-1,0.6887685333365288,
NJH2024_Sub9_MICT_Pre,,
BS2014_Log2(Ratio H/L unmodified peptide),,
WZ2023_Su_005_10min,0.6078416654389066,0.5328176605395396
RM2009_Ratio M/L (M:15 min timepoint;L:0 min. timepoint),,
KBE2022_Log2_Ex_41_T,0.8162144565948978,0.5349067305581409
AMK2021_Ctrl_p1,,
AH2018_LFQ_IT_3_X,,
HS2024_5_PD_T3,0.5322321352013994,
AH2018_TMTMS3_3_X,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as2,,
KBE2022_Log2_Ex_40_U,0.7677334606350444,0.5324632124686858
AH2018_LFQ_M_1_N,,
KBE2022_Log2_Ex_27_U,0.8066909385803166,
HW2015_Ratio M/L normalized Exp3,,
RKK2015_TNF-α/IKKb(K44M),,
AH2018_SILAC_M_1_N,,
HW2015_Ratio M/L normalized Exp1,,
RB2022_5_RecoveryStrength,,
YP2020_Intensity P10_R1_mult_log2,0.789444166354425,
RB2022_7_PreStrength,,
YA2020_Reporter_intensity_Normal_No.4,,
NJH2025_Sub13_HIIT_Pre,,
PG2020_Intensity CT_D,0.5768889542152396,
NJH2025_Sub9_MICT_Post,,
VOI2024_Veh1 mono,,
CK2022_12 16-1,0.6863248403113691,
RN2012_L13,0.6607750660987308,
LG2023_Control-1_intensity,,
RM2024_Intensity D6-3___2,,
KBE2022_Log2_Ex_8_U,0.7985366613171347,0.5250170288525284
SR2019_SKBR3_Biol_repl_3,,
NJH2024_Sub1_MICT_Post,,
HS2024_3_I_T2,0.5919447659788756,
KTGR2014_Ratio M L Normalized Rep2_Rapamycin_0_15,0.5834497621390811,
RM2024_Intensity D0-3___3,,
HS2024_6_I_T2,0.4636493748713651,
CW2012_10 µM Erl/control Experiment 2 Replicate B,,
AS2011_Ratio H/L Protein Inhi_1,,
FSO2013_Ratio H/M normalized Rep2___1,0.4934899384333147,
GRW2016_Ratio M/L normalized SILAC 5a___2,,
CK2022_10 40-1,0.8283913826220859,
NJH2024_Sub12_HIIT_Pre,,
NJH2024_Sub8_MICT_Pre,,
RM2024_Intensity D0-1___1,,
LY2019_P3+,0.4554446005552464,0.5219207613314013
HH2022_Reporter intensity 6,,
RB2022_2_RecoveryStrength,,
KTGR2014_Ratio-AA 15 mins,0.4108147043698192,
AS2011_Ratio H/L Normalized RNAi_2_2,,
KS2014_Intensity pY_N3,,
MV2014_Ratio H/L normalized B1___2 (30 min),,
LY2019_P5-,0.5692972827226851,0.538115072913966
HW2015_Ratio M/L normalized Exp2,,
SR2019_HCC1419_Biol_repl_1,0.6479919812159433,
AH2018_TMTMS2_3_X,,
GF2025_P3_Adh,0.4542779111391565,
SR2019_JIMT1_Biol_repl_2,,
AH2018_TMTMS2_1_C,,
RM2024_Intensity D0-1___2,,
LY2019_P4+,0.5261146091931878,0.5455837074114828
KBE2022_Log2_Ex_19_U,0.7242883882788883,0.5340636219173495
CKC2017_log2 normalized phosphoproteomics_0min_rep#1,,
RB2022_4_PostStrength,,
LG2023_GSK3α-3_intensity,,
YA2020_Reporter_intensity_Cancer_No.1,,
AST2020_Control,,0.540553492549853
JAW2011_Ratio H/L LS1a,0.4932484789496026,
RCJD2014_5min_mean,,
NJH2015_iTRAQ Subject 4 114/115 (Exercise/Basal) (normalized),,
NJH2025_Sub1_MICT_Mid,,
TM2022_S2.12h.C,,
NJH2025_Sub9_MICT_Mid,,
CKC2017_log2 normalized phosphoproteomics_120min_rep#2,,
AS2011_Ratio H/L Normalized Inhi_1_2,,
FSO2013_Ratio M/L normalized Rep2___1,0.5289253733951937,
LG2023_Control-2_intensity,,
NJH2024_Sub8_HIIT_Pre,,
KS2014_Intensity pY_N2,,
RB2022_5_RecoverySprint,,
RB2022_7_RecoverySprint,,
YA2020_Reporter_intensity_Normal_No.3,,
HS2024_8_B_T2,0.5474341344859713,
AH2018_LFQ_1_X,,0.509429027584869
RM2024_Intensity D6-1___1,,
RCJD2014_10min_2,,
FR2021_Norm.Intensity.M,0.7937004246109337,
RM2024_Intensity D0-3___1,,
KS2014_Intensity N2,,0.5324104748385553
HH2022_Reporter intensity 1,,
HH2022_Reporter intensity 2,,
RM2024_Intensity D6-2___2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as1,,
RM2024_Intensity D2-3___2,,
YA2020_Reporter_intensity_Normal_No.5,,
SR2019_MCF7_Biol_repl_1,0.5591408606754265,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as1a,,
HS2024_8_B_T1,0.5118740754183287,
NJH2025_Sub6_HIIT_Pre,,
RNJ2017_Log2_ratio_Tsup:Tstim_D1,,
EP2017_Untreated R#2 log2 ratio,,
SR2019_LM2_Biol_repl_3,,
RB2022_4_RecoveryStrength,,
CR2017_Ratio Replicate 2,,
CW2012_10 µM Erl/control Experiment 2 Replicate A,,
FSO2013_Ratio H/M normalized Rep3,0.4987689562120999,
AR2021_KD 72h,,0.5184287858662378
MV2014_Ratio H/M normalized B2___3 (5 min),,
KBE2022_Log2_Ex_18_U,0.8476080065091584,
AS2011_Ratio H/L Inhi_1_1,,
NJH2024_Sub8_MICT_Post,,
AH2018_TMTMS3_3_C,,
KBE2022_Log2_Ex_9_U,0.718651026073018,
AH2018_SILAC_M_3_N,,
KBE2022_Log2_Ex_13_T,0.788050017868012,0.533759854863642
RM2024_Intensity D0-3,,
SR2019_SKBR3_Biol_repl_1,,
PG2020_Intensity Mock_10h_C,0.5709788032620784,
CF2017_OSE 29,0.4630684093082771,
YB2013_Ratio_H_L_Normalized_in_experiment_1,,
NJH2025_Sub1_HIIT_Post,,
DL2023_24h-2,,
HS2024_7_B_N2,0.5404930139332991,
PG2020_Intensity 10h_A,0.4271705512062623,
RN2012_L12,,
MV2014_Ratio M/L normalized B1___3 (5 min),,
NJH2024_Sub8_MICT_Mid,,
AH2018_LFQ_IT_4_C,,
SAS2015_PLX/AZD_Exp1,,
FR2021_Norm.Intensity.A,0.834904320134528,
FSO2013_Ratio H/M normalized Rep1___1,0.5160878197840542,
JW2015_Intensity cap2,,
BS2014_Log2(Ratio H/L normalized Rep_2),,
NJH2024_Sub6_MICT_Post,,
CK2022_8 40-1,0.7833133644338776,
RB2022_7_RecoveryEndurance,,
NJH2025_Sub12_HIIT_Post,,
EJN2021_4_Ex_Basal,,0.5213505159796129
TM2022_S2.12h.B,,
RN2012_L15,0.6786619397680361,
KS2014_Intensity pY_PV3,,
TM2022_S2.4h.B,,
PG2020_Intensity 4h_A,0.5676657175148834,
FSO2013_Ratio H/M normalized Rep2___2,,
TM2022_mock.4h.B,,
KBE2022_Log2_Ex_24_U,0.7696973106811762,0.5326931768917998
NJH2025_Sub13_MICT_Mid,,
KS2014_Intensity C3,,0.5309213977906037
RB2022_1_PreSprint,,
HS2024_4_I_N1,0.5083055418920823,
CK2022_7 200-1,0.7655104977602403,
CK2022_5 200-1,0.7661979374995997,
CKC2017_log2 normalized phosphoproteomics_120min_rep#3,,
FSO2013_Ratio H/L normalized Rep2___1,0.5691568455632614,
NJH2024_Sub10_HIIT_Mid,,
RB2022_2_PostEndurance,,
AH2018_LFQ_2_C,,
AH2018_SILAC_MR_1_X,,0.5082698823409039
KTGR2014_Ratio H M Normalized Rep1_Rapamycin_0_15,0.4961603183935685,
IMM2018_normalised rep. int. Empty-2,0.5567601887052087,
RM2024_Intensity D4-1,,
KBE2022_Log2_Ex_25_U,0.7744657378392867,0.5331896704152826
AH2018_SILAC_3_C,,
EJN2021_5_Rest_Ins,,0.521367271396607
VOI2024_0.1uM 24 h_3 di,,
RNJ2017_Log2_ratio_Tstim:Trest_D3,,
DB2022_LFQ intensity L2.1,,
FSO2013_Ratio H/M normalized Rep1,0.5038866029665087,
CK2022_4 16-1,0.7559069626272836,
AS2011_Ratio H/L,,
SR2019_MCF7_Biol_repl_4,,
EJN2021_2_Ex_Ins,,0.5281175142288485
AS2011_Ratio H/L Inhi_2_3,,
JAW2011_Ratio H/L LS1a_1,0.4928820939908871,
AH2018_LFQ_1_N,,
SAS2015_PLX/DMSO_Exp1,,
SFR2015_HL_log2_ratio_avg_c,,
JJ2018_Ratio M/L normalized pP2,,
NJH2024_Sub7_MICT_Mid,,
PG2020_Intensity 6h_B,0.3722488041183772,
FSO2013_Ratio H/L normalized Rep3,0.5251282938868562,
GRW2016_Ratio H/L normalized SILAC 2___2,,
RKK2015_IKKb(K44M)+TNF-α/TNF-α,,
JJ2018_Ratio M/L normalized,,
KTGR2014_Ratio-AA 30 mins,0.5564539263672117,
JW2021_After_1,,
NJH2025_Sub2_MICT_Mid,,
HS2024_6_B_N2,0.5649420576960361,
KBE2022_Log2_Ex_9_T,0.7655708978703157,
AH2018_SILAC_IT_2_N,,
AH2018_SILAC_IT_1_X,,
HW2015_Ratio H/L normalized Exp3,,
HS2024_7_PD_T1,0.5092571059111982,
UK2020_UA_2,0.5457123417664885,0.5285019207591645
RM2024_Intensity D2-1___1,,
GF2025_P10_Sph,0.4402078518939223,
WZ2023_Pe_025_20min,0.7103836814246947,0.5316627781260669
JVO2010_Log2 Ratio M/L Normalized aphidicolin,0.4390100505973963,0.5288005849119968
AH2018_LFQ_2_N,,0.5174334045143348
HS2024_4_I_N2,0.6031423059026626,
AH2018_TMTMS2_3_N,,
RN2012_H06,0.5160703772314558,
AS2011_Inhi 1_Ratio H/L normalized by corresponding protein level (H:TAL treatment; L: MA treatment),,
HS2024_4_PD_T3,0.5987968523520881,
WZ2023_Su_005_30min,0.621186090539428,0.5315939621926856
SR2019_HCC1419_Biol_repl_4,0.6005200240879535,
JJ2018_Ratio H/M normalized___2,,
SR2019_JIMT1_Biol_repl_3,0.5217709597156159,
AS2011_Ratio H/L Protein,,
UK2020_HCM_3,0.5471890188033693,0.5276039004325718
NJH2024_Sub10_HIIT_Post,,
CR2017_Ratio Replicate 3.1,0.6633459605838607,
WZ2023_Su_025_10min,0.6417269334201262,0.5321246704453664
AH2018_LFQ_IT_4_X,,
CP2009_Ratio H/L,,
VOI2024_0.1uM 24 h_3 mono,,
RB2022_4_RecoverySprint,,
RM2024_Intensity D6-3,,
WZ2023_Su_005_20min,0.5568979728316505,0.532212094594181
CW2012_10 µM Gef/control Experiment 1 Replicate B,,
SFR2015_HL_log2_ratio_avg_a,,
CW2012_10 µM Erl/control Experiment 3 Replicate A,,
RB2022_1_PreEndurance,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt3a,,
LG2023_GSK3α-2_intensity,,
EP2017_Pervanadate R#1 log2 ratio,,
NJH2025_Sub6_HIIT_Post,,
RB2022_6_RecoverySprint,,
KS2014_Intensity,,0.5316081700861011
MV2014_Ratio H/M normalized A2___1 (2 min),,
PG2020_Intensity 8h_D,0.5773441593742727,
LY2019_P7+,0.5471948442486724,0.5472287453655821
EP2017_Untreated R#1 normalized log2 ratio,,
RN2012_L10,0.5444266896194909,
PG2020_Intensity 4h_C,0.4258454002644155,
EP2017_Mitotic R#3 normalized log2 ratio,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as4,,
DB2022_LFQ intensity L1,,
KBE2022_Log2_Ex_24_T,0.7807105746310113,0.5372930646697774
RB2022_8_PostStrength,,
AH2018_SILAC_IT_2_X,,
HS2024_4_B_T3,0.595889839232854,
NJH2024_Sub2_HIIT_Post,,
HS2024_8_B_N2,0.6433785737820398,
NJH2025_Sub8_HIIT_Pre,,
JJ2018_Ratio H/L normalized pP2___1,,
HS2024_8_I_T2,0.6083537558295493,
KBE2022_Log2_Ex_6_U,0.8288805934611971,0.5300609864857121
LATM2013_Normalized Log2 Ratio (Light/Medium) Reverse,0.363898108630362,
CR2017_Ratio Replicate 1.1,0.4581801295114638,
CKC2017_log2 normalized phosphoproteomics_30min_rep#1,,
MV2014_Ratio M/H normalized B3___2 (30 min),,
CK2022_16 200-1,0.7408312095895184,
VOI2024_0.1uM 2 h_3 di,,
EP2017_Mitotic R#1 normalized log2 ratio,,
GF2025_P9_Sph,0.5651417589107642,
CK2022_6 200-1,0.7638886366586102,
NJH2024_Sub7_MICT_Post,,
AH2018_TMTMS3_2_X,,
NJH2024_Sub8_HIIT_Post,,
DB2022_LFQ intensity R1,,
JW2015_Intensity cap3,,
SR2019_HCC1954_Biol_repl_1,0.4617777313152336,
HS2024_4_I_T2,0.4427872161983932,
NJH2024_Sub2_MICT_Mid,,
VOI2024_0.1uM 2 h_2 mono,,
CP2009_Ratio M/L Normalized (5 nM dasatinib vs Ctrl),,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as3b,,
HS2024_4_PD_T1,0.5368832574194147,
SAS2015_AZD/DMSO_Exp1,,
NJH2024_Sub1_MICT_Mid,,
IMM2018_normalised rep. int. CDK5L-3,0.5645174882948862,
HS2024_3_B_T3,0.5718097025974378,
MV2014_Ratio L/H normalized A3___2 (2 min),,
NJH2025_Sub13_MICT_Pre,,
SR2019_MDAMB231_Biol_repl_3,,
GRW2016_Ratio H/L normalized SILAC 4___1,,
MM2018_Ratio H/L replicate1,0.3568585954820457,
PG2020_Intensity 2h_D,0.6047548157019804,
EP2017_Untreated R#3 normalized log2 ratio,,
MV2014_Ratio M/H normalized A3___3 (10 min),,
NJH2024_Sub7_HIIT_Pre,,
JAW2011_Ratio H/L LS2,0.5359979545467181,
CK2022_8 200-1,0.7703861424809778,
KS2014_Intensity pY_C4,,
CR2017_Ratio Replicate 3.5,0.5532551218140173,
RB2022_7_PostEndurance,,
NJH2025_Sub4_HIIT_Pre,,
CKC2017_log2 normalized phosphoproteomics_90min_rep#3,,
TM2022_mock.12h.A,,
JJ2018_Ratio H/L normalized pP1,,
EP2017_Pervanadate R#2 normalized log2 ratio,,
AS2011_Ratio H/L Normalized by Protein (Unnormalized),,
KS2014_Intensity pY_E5_4,,
RM2024_Intensity D4-3___2,,
CKC2017_log2 normalized phosphoproteomics_15min_rep#1,,
AH2018_SILAC_2_C,,
AS2011_RNAi 2_Ratio H/L normalized by corresponding protein level (H: shPlk1; L: shEg5),,
HS2024_7_I_N1,0.5070964831107454,
KBE2022_Log2_Ex_29_T,0.7721433367401274,
HS2024_7_I_T2,0.4449025991554567,
AS2011_Ratio H/L Normalized RNAi_2_3,,
CW2012_10 µM Gef/control Experiment 3 Replicate B,,
HS2024_6_B_T2,0.5804647728541567,
AMK2021_45I_p5,,
CW2012_10 µM Erl/control Experiment 1 Replicate A,,
SAS2015_PLX/DMSO_Exp2,,
EJN2021_1_Ex_Basal,,0.5195056466916524
FR2021_Intensity.M,0.7937004246109337,
RB2022_2_PostSprint,,
AH2018_SILAC_MR_3_N,,0.5132422539123567
MV2014_Ratio H/L normalized B1___3 (30 min),,
CF2017_FTE 13,0.5633780035238124,
PG2020_Intensity CT_C,0.4012181433197272,
ZCP2016_Ratio H/L Rep 1,,
FS2019_db/db2,,
KS2014_Intensity pY_PV4,,
KBE2022_Log2_Ex_39_U,0.7525367799945718,0.5352772287127724
EP2017_Untreated R#3 log2 ratio,,
RB2022_2_PostStrength,,
AS2011_Ratio H/L Normalized_1,,
MV2014_Ratio M/H normalized A3___2 (10 min),,
CR2017_Ratio Replicate 3.4,0.5765592155550707,
HS2024_8_PD_T2,0.4873552158971808,
FS2019_Ctr2,,
RB2022_6_PreEndurance,,
FR2021_Norm.Intensity.G,0.7973340614374907,
NJH2025_Sub9_HIIT_Post,,
CKC2017_log2 normalized phosphoproteomics_0min_rep#3,,
RM2024_Intensity D4-3,,
HS2024_8_B_N1,0.6088949714881882,
NJH2025_Sub10_MICT_Mid,,
KBE2022_Log2_Ex_15_U,0.7814753729879165,0.5268136869104616
AS2011_Ratio H/L Normalized Inhi_2,,
RKK2015_TNF-α/SC-514,,
RB2022_3_PreSprint,,
CR2017_Ratio Replicate 2.3,0.53495920486717,
RM2009_Ratio M/L Normalized by Corresponding Protein Level (M:15 min timepoint;L:0 min. timepoint),,
CP2009_Ratio H/L Normalized (50 nM dasatinib vs Ctrl),,
GF2025_P4_Adh,0.4570669767288527,
YA2020_Reporter_intensity_Normal_No.2,,
YP2020_Intensity P30_R2_mult_log2,0.6552837632351313,
NJH2025_Sub13_MICT_Post,,
HS2024_4_B_N2,0.554066164771451,
HS2024_3_PD_T3,0.6211118706106424,
AMK2021_120R_p3,,
MV2014_Ratio L/H normalized A3___3 (2 min),,
NJH2025_Sub10_HIIT_Pre,,
FR2021_Intensity.G,0.8249567566985891,
RAM2015_Log2 C,0.5454711324338947,
AS2011_Ratio H/L Proteins Inhi_1,,
FSO2013_Ratio H/M normalized Rep1___3,,
AH2018_LFQ_M_2_N,,0.5242100227298442
MV2014_Ratio M/L normalized A1___3 (2 min),,
KBE2022_Log2_Ex_40_T,0.7526303970483605,0.5326191882215701
CK2022_2 16-1,0.7599400283466271,
RAM2015_Log2 B,0.6691405960040535,
YP2020_Intensity C10_R1_mult_log2,0.7657111310183495,
FSO2013_Ratio M/L normalized Rep1___2,,
NJH2025_Sub8_MICT_Pre,,
EJN2021_4_Rest_Basal,,0.5238130276127487
YB2013_Ratio_H_L_Normalized_in_experiment_2,,
JJ2018_Ratio H/M normalized pP3___1,,
VOI2024_Veh2 mono,,
HS2024_6_B_T1,0.6098852568057617,
UK2020_HCM_5,0.5510378513810847,0.5286829592317042
NJH2025_Sub10_HIIT_Post,,
VOI2024_0.1uM 2 h_3 mono,,
JW2015_Intensity pre3,,
AS2011_Ratio H/L Normalized Inhi_2_1,,
DL2023_24h-3,,
HS2024_7_PD_T3,0.4274646162557324,
PG2020_Intensity Mock_10h_B,,
WZ2023_Su_025_30min,0.6795015133148069,0.5309544558422075
AH2018_LFQ_4_N,,0.5156555777662378
CR2017_Ratio Replicate 1.2,,
AS2011_Ratio H/L Normalized by Proteins,,
RB2022_6_RecoveryStrength,,
HS2024_8_I_N1,0.6305389130756036,
AMK2021_Ctrl_p3,,
AS2011_Ratio H/L Protein Inhi_2,,
HH2022_Reporter intensity 7,,
AH2018_SILAC_M_1_X,,
RB2022_7_PreEndurance,,
VOI2024_0.1uM 24 h_2 di,,
DL2023_control-2,,
LY2019_P6+,0.5097242751263573,0.5452836544431231
DB2022_LFQ intensity R2,,
GF2025_P6_Adh,0.6158353175617771,
VOI2024_Veh1 di,,
AS2011_Ratio H/L RNAi_2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as3,,
VOI2024_Veh3 mono,,
HS2024_5_I_T2,0.6123588824058379,
NJH2025_Sub7_HIIT_Mid,,
MV2014_Ratio H/L normalized B1___1 (30 min),,
RM2009_Ratio H/L (H:60 min timepoint;L:0 min. timepoint),,
RB2022_6_PostSprint,,
KTGR2014_Ratio H L Normalized Rep2_Rapamycin_0_15,0.453047406189517,
AS2011_Ratio H/L Inhi_1,,
AS2011_Ratio H/L Normalized RNAi_1_2,,
AH2018_TMTMS3_2_C,,
SR2019_Hs578T_Biol_repl_4,0.510144968594419,
RB2022_8_PreStrength,,
KS2014_Intensity C5,,0.5302446241269091
RM2024_Intensity D0-1,,
CW2012_10 µM Gef/control Experiment 3 Replicate A,,
YP2020_Intensity P30_R1_mult_log2,0.5608516976498502,
NJH2025_Sub2_HIIT_Pre,,
RB2022_3_RecoveryEndurance,,
RNJ2017_Log2_ratio_Tstim:Trest_D2,,
GF2025_P9_Adh,0.6688295390555569,
RB2022_3_PostStrength,,
TM2022_S2.8h.A,,
AS2011_Ratio H/L RNAi_1_1,,
AS2011_Ratio H/L Normalized by Proteins RNAi_2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt1,,
AS2011_Ratio H/L Normalized by Protein Inhi_1,,
NJH2025_Sub2_MICT_Pre,,
MV2014_Ratio L/M normalized A2___3 (10 min),,
MV2014_Ratio H/M normalized A2___3 (2 min),,
HS2024_4_B_T2,0.5435628893072002,
SR2019_BT549_Biol_repl_1,0.596751036841751,
AH2018_LFQ_M_4_N,,0.5224765781469521
NJH2024_Sub8_HIIT_Mid,,
PG2020_Intensity 8h_B,0.4960709882089948,
AH2018_LFQ_2_X,,
PG2020_Intensity 2h_B,0.4787073073096309,
AS2011_Ratio H/L Proteins RNAi_1,,
RB2022_4_PostSprint,,
KS2014_Intensity E15_3,,
GF2025_P3_Sph,0.5070072218126305,
DB2022_LFQ intensity L2,,
MV2014_Ratio H/L normalized A1___1 (10 min),,
AH2018_SILAC_1_C,,
NJH2024_Sub1_HIIT_Pre,,
FSO2013_Ratio M/L normalized Rep2___2,,
NJH2015_TMT Subject 4 130_N/129_C (Exercise/Basal) (normalized),,
AS2011_Ratio H/L RNAi_2_3,,
AH2018_SILAC_IT_1_N,,
KTGR2014_Ratio H M Normalized Rep2_AA_starvation_0_15,0.4218452747735913,
RB2022_4_PreEndurance,,
JJ2018_Ratio M/L normalized pP1,,
CR2017_Ratio Replicate 2.4,0.5146026493339229,
ZQ2022_N1,0.4823488238604819,
LY2019_P6-,0.5104544084854555,0.543534948985784
RM2024_Intensity D2-3,,
UK2020_HCM_1,0.5494640232133033,
JW2015_Intensity pre2,,
KTGR2014_Ratio M L Normalized Rep1_AA_starvation_0_15,0.4887345488156439,
RM2024_Intensity D2-1,,
NJH2025_Sub12_MICT_Post,,
MV2014_Ratio H/M normalized B2___2 (5 min),,
RN2012_L14,0.5038927429633586,
AH2018_LFQ_3_N,,0.5056651976729364
RKK2015_TNF-α/IKKb,,
SFR2015_HL_log2_ratio_std_b,,
UK2020_UA_1,0.5581986894080327,0.5284399859870622
KBE2022_Log2_Ex_13_U,0.8343914684887548,0.529198980246937
AS2011_Ratio H/L Normalized Inhi_1,,
RNJ2017_Log2_ratio_Tsup:Trest_D2,,
RB2022_1_RecoverySprint,,
CKC2017_log2 normalized phosphoproteomics_120min_rep#1,,
JJ2018_Ratio H/L normalized pP3,,
CK2022_7 40-1,0.7768320234441577,
AS2011_Ratio H/L Inhi_1_3,,
NJH2025_Sub10_HIIT_Mid,,
KTGR2014_Ratio H L Normalized Rep2_AA_starvation_0_15,0.5054566958859261,
JAW2011_Ratio H/L LS1b_1,,
PG2020_Intensity 4h_B,0.4731441247169459,
SR2019_BT549_Biol_repl_2,0.4738190940483211,
RM2024_Intensity D4-2,,
DB2022_LFQ intensity R2.2,,
JJ2018_Ratio H/L normalized,,
RB2022_5_PostEndurance,,
HS2024_5_PD_T2,0.5782406807629134,
WZ2023_Su_025_20min,0.5696575384310046,0.5309167623826415
RM2024_Intensity D2-2___1,,
IMM2018_normalised rep. int. CDK5L-2,0.5801812602654416,
LY2019_P8-,0.460699798501552,0.5219159821658287
JVO2010_Ratio H/M Normalized by Protein ThymON - Log2 G2,0.5346215302327584,0.5303512617206043
CKC2017_log2 normalized phosphoproteomics_15min_rep#3,,
FSO2013_Ratio H/L normalized Rep1,0.523329912728212,
NJH2024_Sub2_HIIT_Pre,,
CKC2017_log2 normalized phosphoproteomics_60min_rep#2,,
CK2022_13 40-1,0.7025523352164796,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt4a,,
RN2012_H02,0.3708087599509523,
PG2020_Intensity 10h_D,0.4463676915134157,
RB2022_8_PreEndurance,,
HS2024_3_B_N2,0.6295205494500596,
EJN2021_4_Ex_Ins,,0.5252590755785504
AS2011_Ratio H/L Normalized by Protein,,
EJN2021_1_Ex_Ins,,0.5226397170439586
EP2017_Pervanadate R#3 log2 ratio,,
FSO2013_Ratio M/L normalized Rep1___3,,
NJH2025_Sub4_HIIT_Mid,,
RCJD2014_5min_2,,
RB2022_6_PostStrength,,
AH2018_SILAC_MR_3_C,,0.5118239219297652
AH2018_LFQ_M_4_C,,
NJH2024_Sub4_MICT_Pre,,
AS2011_Ratio H/L Normalized Inhi_1_1,,
DL2023_12h-1,,
MV2014_Ratio L/M normalized B2___1 (30 min),,
DB2022_LFQ intensity L1.1,,
NJH2025_Sub6_MICT_Pre,,
NJH2025_Sub6_MICT_Post,,
CKC2017_log2 normalized phosphoproteomics_60min_rep#3,,
RN2012_H04,0.3625503096437215,
CK2022_6 40-1,0.7805756553279818,
DB2022_LFQ intensity R2.1,,
KBE2022_Log2_Ex_42_U,0.8070091437030613,0.5306627743009926
LY2019_P3-,0.6635361201990738,0.5249236663181204
FR2021_Intensity.A,0.8062897241323952,
EJN2021_3_Ex_Ins,,0.5299659598802763
MV2014_Ratio M/L normalized A1___1 (2 min),,
WZ2023_Pe_005_30min,0.6925393744430157,0.5309432989422836
HS2024_8_PD_T3,0.5632583550975341,
EJN2021_3_Ex_Basal,,0.5211039015428321
AST2020_Control.1,,0.5422116091759476
JW2015_Intensity cap1,,
PG2020_Intensity CT_A,0.4608257564560585,
FS2019_Ctr3,,
WZ2023_Pu_025_20min,0.6016542019002279,0.5326884654163242
NJH2025_Sub4_MICT_Post,,
JVO2010_Ratio H/M Normalized by Protein Noco3h - Log2 Late S,0.558793571142393,0.5384086086904826
GF2025_P10_Adh,0.546702485534611,
RB2022_1_RecoveryStrength,,
SR2019_HCC1954_Biol_repl_4,0.4729499344245681,
FR2021_Norm.Intensity.N,0.811147130692094,
HS2024_5_B_N1,0.5779104157417696,
FSO2013_Ratio H/M normalized Rep3___3,,
AH2018_TMTMS2_2_C,,
RB2022_4_PreSprint,,
DB2022_Intensity R2,,
AH2018_TMTMS2_Pool,,
HS2024_8_I_N2,0.5812428082207453,
RB2022_3_RecoveryStrength,,
NJH2024_Sub6_HIIT_Mid,,
AH2018_SILAC_M_1_C,,
LY2019_P8+,0.5873783656660058,0.5154467393377732
RB2022_2_RecoveryEndurance,,
JJ2018_Ratio H/M normalized pP2___1,,
JAW2011_Ratio H/L HS_1,0.5505397871745297,
RB2022_3_PostEndurance,,
KS2014_Intensity pY_PV1,,
JAW2011_Ratio H/L LS1b_2,,
SR2019_MCF7_Biol_repl_2,,
NJH2015_TMT Subject 2 128_N/127_C (Exercise/Basal) (normalized),,
AS2011_Ratio H/L Normalized RNAi_1_1,,
AH2018_LFQ_M_4_X,,
NJH2024_Sub6_MICT_Pre,,
JJ2018_Ratio M/L normalized pP1___2,,
YP2020_Intensity C30_R2_mult_log2,0.7917609972091137,
NJH2024_Sub9_HIIT_Pre,,
AS2011_Ratio H/L Normalized Inhi_2_3,,
RM2024_Intensity D0-1___3,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt3,,
KBE2022_Log2_Ex_28_U,0.7454010344462626,0.5366542366718884
GRW2016_Ratio H/L normalized SILAC 1___1,,
CF2017_FTE 17,0.421087957984259,
LY2019_P2-,0.4544386538964715,0.5563639394648195
AH2018_LFQ_IT_1_X,,
JJ2018_Ratio H/L normalized pP3___1,,
RB2022_8_RecoveryStrength,,
WZ2023_Pe_005_20min,0.6692058058682894,0.5316344107773573
AST2020_Control.2,,0.5415779270834594
NJH2025_Sub6_MICT_Mid,,
RCJD2014_10min_1,,
FSO2013_Ratio H/L normalized Rep2___3,,
JVO2010_Ratio M/L Normalized by Protein Noco3h - Log2 G1,0.5139642432047962,0.5234654993779503
HS2024_3_I_T1,0.4902141376572685,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as2a,,
CK2022_4 40-1,0.8021270221398622,
SR2019_MCF10A_Biol_repl_4,0.6262442657396353,
KS2014_Intensity pY_C5,,
NJH2025_Sub4_MICT_Pre,,
NJH2024_Sub9_MICT_Post,,
CF2017_OSE 28,0.3227498965349176,
HS2024_5_B_T2,0.5312153676796983,
HS2024_6_I_T1,0.4496978855051445,
HS2024_5_B_T3,0.5310480637622969,
JJ2018_Ratio H/M normalized pP1___1,,
KBE2022_Log2_Ex_36_U,0.8116716671525014,
AH2018_TMTMS3_3_N,,
SR2019_HCC1419_Biol_repl_2,0.5696404811542427,
FR2021_Intensity.N,0.8111107449595711,
AS2011_Ratio H/L Inhi_2_1,,
AH2018_SILAC_MR_1_C,,0.5035036950338924
NJH2024_Sub1_HIIT_Mid,,
NJH2025_Sub8_HIIT_Mid,,
EP2017_Mitotic R#3 log2 ratio,,
KBE2022_Log2_Ex_36_T,0.8209789922238808,
NJH2025_Sub6_HIIT_Mid,,
WZ2023_Pu_005_30min,0.6903101548624944,0.5319387275134839
KS2014_Intensity C2,,0.5313571416307757
FSO2013_Ratio H/L normalized Rep1___2,,
RM2024_Intensity D2-2,,
KBE2022_Log2_Ex_42_T,0.7695051277937576,0.5342733204190857
CK2022_9 200-1,0.7929652213496722,
GRW2016_Ratio H/L normalized SILAC 2___1,,
JJ2018_Ratio H/M normalized pP3___2,,
DB2022_LFQ intensity R1.1,,
CK2022_10 200-1,0.801898621018669,
NJH2024_Sub9_MICT_Mid,,
JAW2011_Ratio H/L_2,,
HS2024_7_I_N2,0.5015091336231862,
RBK2021_1332T Late,,
LY2019_P1-,0.6350441352133471,0.5497372435010418
RKK2015_TNF-α/basal.1,,
RKK2015_TNF-α/TNF-α+SC-514,,
CR2017_Ratio Replicate 2.5,0.573473468452287,
HS2024_3_I_T3,0.5612941780359239,
CKC2017_log2 normalized phosphoproteomics_90min_rep#2,,
AS2011_Ratio H/L Normalized RNAi_1,,
KS2014_Intensity E15_4,,
ZQ2022_C3,0.6256738483166273,
EJN2021_3_Rest_Ins,,0.5275511111556573
YP2020_Intensity P10_R2_mult_log2,0.793077987127743,
MV2014_Ratio H/L normalized A1___3 (10 min),,
NJH2025_Sub1_MICT_Pre,,
KBE2022_Log2_Ex_39_T,0.7465995288337839,0.5364957177531879
FSO2013_Ratio H/M normalized Rep3___2,,
RM2024_Intensity D6-2,,
EP2017_Untreated R#1 log2 ratio,,
RKK2015_SC-514/basal,,
RM2024_Intensity D6-1___3,,
WZ2023_Pu_010_10min,0.504100204856549,0.5334848290376869
NJH2025_Sub9_HIIT_Mid,,
SR2019_SKBR3_Biol_repl_4,,
HS2024_5_I_T3,0.5472571013809503,
KS2014_Intensity N1,,0.529867621113136
NJH2024_Sub12_MICT_Post,,
TM2022_S2.8h.C,,
CR2017_Ratio Replicate 1,0.6155677966455544,
AS2011_RNAi 1_Ratio H/L normalized by corresponding protein level (H: shPlk1; L: shEg5),,
CKC2017_log2 normalized phosphoproteomics_30min_rep#3,,
JJ2018_Ratio H/M normalized pP3,,
AH2018_SILAC_MR_2_C,,0.5061594959002151
LATM2013_Log2 Ratio (Medium/Light) Forward,0.372311145859004,
PG2020_Intensity 2h_A,0.521817610670631,
NJH2024_Sub6_MICT_Mid,,
NJH2025_Sub13_HIIT_Post,,
AH2018_SILAC_MR_3_X,,0.5034654960388564
JJ2018_Ratio H/M normalized___1,,
RCJD2014_15min_2,,
AS2011_Ratio H/L_2,,
AS2011_Ratio H/L Normalized,,
RN2012_H03,,
HS2024_5_B_N2,0.5739433397981601,
HS2024_5_I_N1,0.5966238445232618,
HS2024_6_I_N1,0.5016379254101281,
AR2021_KD 48h,,0.5524497230868451
FR2021_Intensity.B,0.8334094981564871,
RB2022_3_PreEndurance,,
HS2024_5_I_T1,0.5606973102836778,
NJH2024_Sub10_MICT_Pre,,
SR2019_LM2_Biol_repl_2,0.4972604292482756,
AST2020_anti-CD3,,0.5411012987762072
SR2019_MDAMB231_Biol_repl_1,,
RM2024_Intensity D2-3___3,,
WZ2023_Pe_005_10min,0.6885060359251646,0.5315049985683952
KBE2022_Log2_Ex_29_U,0.7591631361181747,
HS2024_7_B_T1,0.5782227618475759,
AH2018_LFQ_M_2_X,,
AH2018_LFQ_IT_4_N,,
CK2022_15 200-1,0.7489719659434739,
RM2024_Intensity D4-1___2,,
JJ2018_Ratio H/M normalized,,
JJ2018_Ratio M/L normalized pP3___1,,
KBE2022_Log2_Ex_34_T,0.8069240840102272,0.5319239865330375
CKC2017_log2 normalized phosphoproteomics_0min_rep#2,,
LY2019_P2+,0.5246907870707245,0.5260502185754979
LATM2013_Log2 Ratio (Light/Medium) Reverse,0.3652587258401156,
CK2022_2 200-1,0.7970062161719631,
AS2011_Ratio H/L Protein RNAi_2,,
MV2014_Ratio L/H normalized A3___1 (2 min),,
WZ2023_Su_010_30min,0.5707369788940168,0.5320038716924909
RN2012_H01,0.5605430769712374,
KTGR2014_Ratio-Rapa 2 mins,0.5475437011734765,
EJN2021_2_Rest_Basal,,0.5270712825281564
KS2014_Intensity pY_E5_3,,
MM2018_Ratio H/L replicate 3,0.4542938358515477,
EP2017_Pervanadate R#1 normalized log2 ratio,,
HS2024_8_B_T3,0.5923405539617143,
YA2020_Reporter_intensity_Cancer_No.3,,
KBE2022_Log2_Ex_44_U,0.761990106560172,0.5321412088495454
WZ2023_Pe_010_20min,0.6977527124286813,0.5310527162343903
KS2014_Intensity pY_C6,,
AS2011_Ratio H/L Normalized_3,,
RCJD2014_15min_mean,,
RB2022_3_PreStrength,,
NJH2015_iTRAQ Subject 3 116/117 (Exercise/Basal) (normalized),,
RCJD2014_10min_mean,,
KS2014_Intensity C1,,0.5287821393328861
FSO2013_Ratio H/M normalized Rep3___1,0.4996325394020782,
AH2018_SILAC_M_3_C,,
RKK2015_TNF-α+IKKb/TNF-α,,
RM2024_Intensity D0-3___2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt2a,,
AH2018_SILAC_M_2_C,,
AH2018_SILAC_M_2_X,,
KTGR2014_Ratio-Rapa 15 mins,0.4455418489882214,
RM2024_Intensity D4-2___1,,
KBE2022_Log2_Ex_15_T,0.7987611446676335,0.5305597656470764
VOI2024_0.1uM 24 h_1 di,,
WZ2023_Su_010_10min,0.5729594491307424,0.5312352337340601
PG2020_Intensity 6h_C,0.4660591563783219,
JVO2010_Ratio M/L Normalized by Protein Noco45 - Log2 mitosis,0.3249152372846607,0.5148252215973591
JJ2018_Ratio M/L normalized pP1___1,,
AH2018_LFQ_M_3_N,,0.5143083573219854
VOI2024_0.1uM 24 h_2 mono,,
AH2018_TMTMS2_3_C,,
CK2022_15 16-1,0.653074629653084,
CK2022_3 16-1,0.7599734789471402,
LY2019_P4-,0.6032981429691664,0.5443335472575278
FSO2013_Ratio H/L normalized Rep3___2,,
KS2014_Intensity pY_PV2,,
HS2024_3_I_N2,0.579803823384787,
GF2025_P8_Adh,0.6899724637160479,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.2-2,,
GF2025_P5_Sph,0.5350779354340277,
CK2022_10 16-1,0.7619103547804846,
KTGR2014_Ratio H L Normalized Rep1_AA_starvation_0_15,0.563622961118728,
VOI2024_0.1uM 2 h_2 di,,
NJH2015_TMT Pool 131/130_C (Exercise/Basal) (normalized),,
NJH2024_Sub2_HIIT_Mid,,
AMK2021_45I_p3,,
NJH2024_Sub13_HIIT_Mid,,
DB2022_LFQ intensity R1.2,,
DB2022_Intensity R1,,
NJH2024_Sub12_MICT_Mid,,
KTGR2014_Ratio M L Normalized Rep1_Rapamycin_0_15,0.4410785072680977,
UK2020_HCM_4,0.5419351040258469,0.5295650389149841
SAS2015_AZD/DMSO_Exp2,,
IMM2018_normalised rep. int. CDK5L-1,0.5818795498214402,
DB2022_LFQ intensity L2.2,,
KTGR2014_Ratio H M Normalized Rep1_AA_starvation_0_15,0.5240742051887001,
EP2017_Mitotic R#1 log2 ratio,,
EJN2021_2_Ex_Basal,,0.5218142299045943
RM2009_Ratio H/L Normalized by Corresponding Protein Level (H:60 min timepoint;L:0 min. timepoint),,
KTGR2014_Ratio-Rapa 30 mins,0.4083486283173951,
CKC2017_log2 normalized phosphoproteomics_90min_rep#1,,
CF2017_FTE 16,0.5697402840696835,
AR2021_L41 10 μM,,0.5296373562921713
CF2017_EOC 2,0.5876166186981598,
RB2022_6_PostEndurance,,
AH2018_SILAC_1_N,,
NJH2024_Sub10_HIIT_Pre,,
AS2011_Ratio H/L Inhi_1_2,,
UK2020_HCM_6,0.550586551158162,0.5301201672897337
RB2022_7_PreSprint,,
NJH2024_Sub2_MICT_Pre,,
HS2024_3_PD_T2,0.5621311775483759,
CK2022_6 16-1,0.7294702294127751,
ZX2022_CB treated Replicate 1,0.6863929791248354,
BS2014_Log2(Ratio H/L normalized Rep_3),,
TM2022_mock.12h.C,,
GRW2016_Ratio M/L normalized SILAC 5a___1,,
HH2022_Reporter intensity 0,,
RM2024_Intensity D2-2___2,,
JC2019_Normalised_intensity_B_TiOx_Testis_sample_URO0126,,
RB2022_1_PreStrength,,
JJ2018_Ratio H/M normalized pP2___2,,
AH2018_TMTMS2_2_X,,
AR2021_L41 1 μM,,0.5373907444375986
JJ2018_Ratio H/M normalized pP1___2,,
AH2018_TMTMS2_1_N,,
NJH2025_Sub10_MICT_Pre,,
JVO2010_Ratio H/M Normalized by Protein Noco45 - Log2 early S,0.4664416365395795,0.5395549944621095
ZX2022_Control Replicate 3,0.6897786884261827,
KS2014_Intensity C4,,0.5285482656890349
AS2011_Ratio H/L Inhi_2,,
KBE2022_Log2_Ex_18_T,0.6947479020395667,
NJH2025_Sub9_MICT_Pre,,
RCJD2014_20min_1,,
MV2014_Ratio H/M normalized B2___1 (5 min),,
FSO2013_Ratio M/L normalized Rep2___3,,
JC2019_Normalised_intensity_C_TiOx_Testis_sample_URO0158,,
SR2019_MCF10A_Biol_repl_3,0.591582548676073,
HS2024_7_B_T2,0.6059928487286627,
SAS2015_PLX/DMSO_Exp3,,
AMK2021_Ctrl_p5,,
NJH2025_Sub2_HIIT_Mid,,
AH2018_LFQ_M_3_C,,0.5191222406753722
CKC2017_log2 normalized phosphoproteomics_15min_rep#2,,
YA2020_Reporter_intensity_Cancer_No.2,,
FSO2013_Ratio H/M normalized Rep2___3,,
RB2022_8_PreSprint,,
AH2018_SILAC_IT_3_C,,
WZ2023_Pu_025_10min,0.7104598485514018,0.5326015290513889
RM2024_Intensity D2-2___3,,
AS2011_Ratio H/L_1,,
RCJD2014_10min_3,,
FSO2013_Ratio M/L normalized Rep3___1,0.4825824523173093,
SR2019_JIMT1_Biol_repl_4,,
YP2020_Intensity C10_R2_mult_log2,0.785797071884422,
ZCP2016_Ratio H/L Rep 2,,
CF2017_EOC 4,0.5472475957715649,
JJ2018_Ratio H/L normalized pP1___1,,
WZ2023_Pe_010_30min,0.7118786057269927,0.530649431512812
MV2014_Ratio L/M normalized B2___3 (30 min),,
AH2018_LFQ_IT_3_N,,
KS2014_Intensity C6,,0.5355500449302455
ZQ2022_N3,0.461360962888153,
HW2015_Ratio H/L normalized Exp1,,
CK2022_12 40-1,0.7224181022911361,
NJH2024_Sub7_MICT_Pre,,
ZX2022_Control Replicate 1,0.6965371751827107,
JJ2018_Ratio H/M normalized pP1,,
CK2022_16 40-1,0.674947542273438,
AH2018_SILAC_IT_2_C,,
CK2022_5 40-1,0.7704961334894407,
AH2018_LFQ_3_X,,
UK2020_UA_3,0.5443872474523066,0.5280456030580909
LY2019_P7-,0.5042740525204076,0.5378945443570831
GF2025_P5_Adh,0.4371805470540058,
RB2022_1_PostStrength,,
JAW2011_Ratio H/L LS1b,,
FSO2013_Ratio H/L normalized Rep3___1,0.5269807187796942,
SR2019_HCC1954_Biol_repl_3,0.4706361092577328,
CR2017_Ratio Replicate 2.2,0.6222034713190189,
VOI2024_0.1uM 2 h_1 mono,,
MV2014_Ratio L/M normalized A2___1 (10 min),,
RNJ2017_Log2_ratio_Tsup:Tstim_D3,,
CK2022_11 16-1,0.7493711013439198,
ZQ2022_C1,0.5550828347131439,
CR2017_Ratio Replicate 2.1,,
PG2020_Intensity CT_B,,
JJ2018_Ratio M/L normalized___2,,
AH2018_SILAC_MR_1_N,,0.503277661978924
KS2014_Intensity pY_E5_1,,
JW2021_Before_3,,
NJH2015_iTRAQ Subject 2 117/116 (Exercise/Basal) (normalized),,
MV2014_Ratio M/H normalized B3___3 (30 min),,
FS2019_db/db1,,
NJH2025_Sub9_HIIT_Pre,,
JAW2011_Ratio H/L_1,0.5193274697986034,
RCJD2014_20min_3,,
AH2018_LFQ_3_C,,0.511221307105317
JJ2018_Ratio M/L normalized pP3___2,,
AMK2021_45I_p1,,
NJH2025_Sub8_HIIT_Post,,
AH2018_LFQ_M_3_X,,0.5274552219902554
YA2020_Reporter_intensity_Cancer_No.4,,
KS2014_Intensity pY_E5_2,,
FSO2013_Ratio H/L normalized Rep1___3,,
GF2025_P4_Sph,0.4699807266292096,
RB2022_2_PreEndurance,,
JW2021_Before_1,,
KBE2022_Log2_Ex_25_T,0.7780610395162456,0.5372987290879734
AS2011_Ratio H/L Normalized by Proteins Inhi_2,,
MV2014_Ratio L/M normalized A2___2 (10 min),,
JJ2018_Ratio M/L normalized___1,,
FR2021_Intensity.H,0.8129481987926824,
CK2022_14 16-1,0.6675830745267285,
AST2020_anti-CD3+PDL2,,0.5412673534433737
MV2014_Ratio M/L normalized B1___1 (5 min),,
KBE2022_Log2_Ex_19_T,0.7501909011478486,0.5238772248775728
KS2014_Intensity pY_N1,,
RB2022_1_RecoveryEndurance,,
FSO2013_Ratio H/M normalized Rep1___2,,
HS2024_8_I_T1,0.463475453229479,
NJH2015_iTRAQ Subject 1 115/114 (Exercise/Basal) (normalized),,
EP2017_Mitotic R#2 log2 ratio,,
AH2018_TMTMS2_1_X,,
KTGR2014_Ratio M L Normalized Rep2_AA_starvation_0_15,0.5752664095524613,
ZCP2016_Ratio H/L Rep 3,,
AS2011_Ratio H/L Normalized RNAi_1_3,,
SR2019_MCF10A_Biol_repl_1,0.5912477233101344,
NJH2025_Sub8_MICT_Mid,,
EJN2021_5_Ex_Ins,,0.48791363014902606
HS2024_6_I_N2,0.4921809539486453,
HH2022_Reporter intensity 4,,
RBK2021_1326T Late,,
TM2022_mock.12h.B,,
NJH2024_Sub12_MICT_Pre,,
RCJD2014_15min_3,,
MV2014_Ratio L/H normalized B3___2 (5 min),,
LG2023_Control-3_intensity,,
JJ2018_Ratio H/L normalized pP3___2,,
CF2017_FTE 15,0.3778092358848839,
HS2024_4_I_T3,0.551568255870173,
AH2018_SILAC_1_X,,
PG2020_Intensity 10h_B,0.4827658901894628,
AH2018_TMTMS3_1_X,,
CF2017_FTE 14,0.5530341461505422,
NJH2024_Sub13_HIIT_Post,,
RM2024_Intensity D6-3___3,,
NJH2025_Sub7_HIIT_Pre,,
RBK2021_1259T Early,,
RKK2015_IKK+TNF-α/IKKb,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as1b,,
PG2020_Intensity 6h_A,0.5464304077330855,
SR2019_HCC1419_Biol_repl_3,0.6297525446315181,
KBE2022_Log2_Ex_14_T,0.84298553757888,0.5332582079202165
EP2017_Untreated R#2 normalized log2 ratio,,
RM2024_Intensity D0-2___1,,
DB2022_Intensity L1,,
LY2019_P5+,0.5298219681985541,0.5378523181918996
HS2024_5_I_N2,0.6167496035563819,
SAS2015_PLX/AZD_Exp3,,
EP2017_Pervanadate R#2 log2 ratio,,
AS2011_Ratio H/L Normalized RNAi_2_1,,
